Home > Financial Ratios > BAL PHARMA

BAL PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 8.608.018.728.867.21

What is the latest EV/Core EBITDA ratio of BAL PHARMA ?

The latest EV/Core EBITDA ratio of BAL PHARMA is 8.60 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20258.60
Mar20248.01
Mar20238.72
Mar20228.86
Mar20217.21

How is EV/Core EBITDA of BAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 8.6
7.37
Mar2024 8.01
-8.14
Mar2023 8.72
-1.58
Mar2022 8.86
22.88
Mar2021 7.21 -

Other Financial Ratios of BAL PHARMA


Compare EV/Core EBITDA ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹114.5 Cr -3.9% -5.7% -38.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,494.0 Cr -1.5% -4.8% -4.2% Stock Analytics
DIVIS LABORATORIES ₹170,514.0 Cr -0.9% -1.4% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,044.0 Cr 0.3% 1.6% 12.1% Stock Analytics
CIPLA ₹121,574.0 Cr -0.8% -1.2% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,919.0 Cr -0.8% 1.7% -5.6% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-3.9%

-5.7%

-38.8%

SENSEX

0.7%

0.5%

9%


You may also like the below Video Courses